Jeffrey M. Dayno - Nov 1, 2022 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Christian Ulrich , Attorney-in-Fact
Stock symbol
HRMY
Transactions as of
Nov 1, 2022
Transactions value $
-$703,259
Form type
4
Date filed
11/2/2022, 04:04 PM
Previous filing
Oct 20, 2021
Next filing
Nov 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRMY Common Stock Options Exercise $123K +15K $8.22* 15K Nov 1, 2022 Direct
transaction HRMY Common Stock Sale -$827K -15K -100% $55.10 0 Nov 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Options Exercise $0 -15K -28.05% $0.00 38.5K Nov 1, 2022 Common Stock 15K $8.22 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.62. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The stock option vests in five equal annual installments beginning on November 1, 2018.
F4 The Form 4 filed by the reporting person on October 20, 2021, understated the number of securities owned following the reported transaction by 1 share. The amount of securities reported herein reflects the correct number of securities owned following the transactions reported on this Form 4.